Study on a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) Compared to Two Meningococcal Reference Vaccines in European Toddlers

NCT03890367 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

707

Enrollment

INDUSTRY

Sponsor class

Conditions

Meningococcal Immunisation (Healthy Volunteers)

Interventions

BIOLOGICAL: Meningococcal polysaccharide (serogroups A, C, Y, and W) tetanus toxoid Conjugate vaccine
BIOLOGICAL: Meningococcal polysaccharide group A, C, W-135 and Y Conjugate vaccine
BIOLOGICAL: Meningococcal group C polysaccharide Conjugate vaccine adsorbed

Sponsor

Sanofi Pasteur, a Sanofi Company